Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flows from Operating Activities:
Net income	$ 10,630	$ 14,557
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,001	2,852
Amortization on right-of-use assets	2,505
Provision (Recovery) for bad debts	1,711	(652)
Deferred income tax - net	2,481	3,701
Stock issued for costs and expenses	1,990	1,955
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(6,808)	(5,025)
Notes receivable	22	(13)
Costs and estimated earnings in excess of billings on uncompleted contracts	372	(248)
Inventories	23	(378)
Prepaid expenses and other current assets	570	(214)
Other assets	(142)
Increase (decrease) in operating liabilities, net:
Accounts payable	(175)	331
Other current liabilities	(193)	(3,593)
Operating lease liabilities	(2,216)
Customer deposits	56	(24)
Other liabilities	105	18
Due to related party medical practices		(135)
Net cash provided by operating activities	13,932	13,132
Cash Flows from Investing Activities:
Purchases of property and equipment	(6,601)	(3,069)
Proceeds/(Purchase) of Short term investment	15,063	(15,000)
Cost of patents	(79)	(88)
Net cash used in investing activities	8,383	(18,157)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(33)	(23)
Repayment of notes receivable from employee stockholders		9
Distributions to noncontrolling interests	(5,145)	(4,815)
Net cash used in financing activities	(5,178)	(4,829)
Net Increase (decrease) in Cash and Cash Equivalents	17,137	(9,854)
Cash and Cash Equivalents - Beginning of Period	13,882	19,634
Cash and Cash Equivalents - End of Period	$ 31,019	$ 9,780